News

Net profit of Amrutanjan Health Care rose 6.65% to Rs 16.19 crore in the quarter ended March 2026 as against Rs 15.18 crore during the previous quarter ended March 2025. Sales rose 10.60% to Rs 149.77 crore in the quarter ended March 2026 as against Rs 135.41 crore during the previous quarter ended March 2025.For the full year,net profit rose 13.95% to Rs 57.92 crore in the year ended March 2026 as against Rs 50.83 crore during the previous year ended March 2025. Sales rose 11.23% to Rs 502.55 crore in the year ended March 2026 as against Rs 451.82 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales149.77135.41 11 502.55451.82 11 OPM %17.0613.07 -15.0612.88 - PBDT30.2322.48 34 93.0775.66 23 PBT28.6220.86 37 86.7569.13 25 NP16.1915.18 7 57.9250.83 14 Powered by Capital Market - Live News

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 08 May 2026, has recommended a Final Dividend of Rs.2.90 per share (i.e.290%), subject to the approval of the shareholders.

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 8 May 2026.

Net profit of Amrutanjan Health Care rose 1.04% to Rs 19.45 crore in the quarter ended December 2025 as against Rs 19.25 crore during the previous quarter ended December 2024. Sales rose 14.90% to Rs 141.04 crore in the quarter ended December 2025 as against Rs 122.75 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales141.04122.75 15 OPM %17.8419.02 - PBDT29.2327.65 6 PBT27.6125.99 6 NP19.4519.25 1 Powered by Capital Market - Live News

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 03 February 2026, has recommended a Second Interim Dividend of Rs.1 per share (i.e.100%), subject to the approval of the shareholders.Powered by Capital Market - Live News